1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and and Prevention (CDC). This grant aims to support early-career scientists transitioning into entrepreneurship by funding research and development efforts at small business concerns. It also includes entrepreneurial training and mentoring.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) Agency: National Institutes of Health Assistance Listings: 93. 866 -- Aging Research 93. 172 -- Human Genome Research 93.
113 -- Environmental Health 93. 839 -- Blood Diseases and Resources Research 93. 213 -- Research and Training in Complementary and Integrative Health 93.
233 -- National Center on Sleep Disorders Research 93. 865 -- Child Health and Human Development Extramural Research 93. 279 -- Drug Use and Addiction Research Programs 93.
840 -- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders 93. 837 -- Cardiovascular Diseases Research 93. 879 -- Medical Library Assistance 93.
173 -- Research Related to Deafness and Communication Disorders 93. 273 -- Alcohol Research Programs 93. 121 -- Oral Diseases and Disorders Research 93.
838 -- Lung Diseases Research 93. 867 -- Vision Research 93. 846 -- Arthritis, Musculoskeletal and Skin Diseases Research 93.
143 -- NIEHS Superfund Hazardous Substances_Basic Research and Education 93. 847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research 93. 859 -- Biomedical Research and Research Training 93.
350 -- National Center for Advancing Translational Sciences 93. 361 -- Nursing Research Last Updated: May 27, 2026 View version history on Grants.
gov The National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC), including the participating Institutes, Centers and Offices, intend to publish a Notice of Funding Opportunity (NOFO) to invite eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) Phase I, and Fast-Track (NIH only) grant applications for the Small Business Transition Grant.
Through this NOFO, NIH and CDC will support early-career scientists as they transition into entrepreneurship. In addition to funding research and development efforts at the SBC, a major component of this NOFO is entrepreneurial training, mentoring, and career development of the PD/PI. Applications are not being solicited at this time.
Notice is being provided to allow potential applicants sufficient time to develop responsive projects, including identification of complementary industry mentors and career development resources. This NOFO will utilize the R43/R44 activity code.
United States small businesses that have the research capabilities and technological expertise to contribute to the R&D mission(s) of the NIH and CDC awarding components identified in this NOFO are encouraged to begin to consider applying for this new NOFO. This opportunity is available to first-time Principal Investigators, and key personnel must include a mentor with measurable effort committed to the project.
Only United States small business concerns (SBCs), as defined by the Small Business Administration (SBA)(sbir. gov/apply) are eligible to submit applications for this opportunity. Individuals are eligible to serve as the PD/PI if they have never been an independent PD/PI on an NIH or CDC research, or corresponding non-NIH peer-reviewed research grant, and are a U.S. Citizen or Lawful Permanent Resident.
Grantor contact information NIH SEED (Small business Education and Entrepreneurial Development) Office of Extramural Research (OER) No documents are currently available.
Link to additional information Estimated Application Due Date : Estimated Due Date Description : Estimated Project Start Date : Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.
According to the current listing, eligibility includes: United States small business concerns (SBCs). Confirm the full requirements in the official notice before applying.
The current listing shows varies (normally may not exceed $306,872 for Phase I, and $2,045,816 for Phase II, unless proposal falls under one of the approved topics). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) is funded by National Institutes of Health (NIH) and Centers for Disease Control and and Prevention (CDC). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
CDC-RFA-EH-27-0074 posted as a forecast September 22, 2026: 6 expected awards at $750,000 to $900,000. That is flat funding against the expiring cycle — and the only proven way in is the consortium model Arizona used to bring three states under one award.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article